

The transition from the EU Clinical Trials Directive (CTD) to the new Clinical Trials Regulation (CTR) represents a major shift in how trials will be conducted across Europe. While this overhaul aims to streamline processes, navigating EU CTR is complex. We have distilled recommendations from the EU Clinical Trials Coordination and Advisory Group (CTAG) into actionable checklists to aid in planning, and our proposed workflow highlights steps to help sponsors navigate the transition process.
You can also download the PDF by clicking the button below
Related Products

TrialScope Disclose
The most widely trusted solution for clinical trial disclosure management

TrialScope Intelligence
A centralized, interactive repository of the critical regulatory knowledge needed for global clinical trial disclosure compliance

Pink Sheet
The leader in pharmaceutical news and regulatory trend analysis
Related Resources